{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:19:47Z","timestamp":1788639587434,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:p>\n                    To investigate the potential effect of repeated intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) drugs on corneal nerves. A total of 64 patients were treated with intravitreal injection of anti-VEGF drugs. There were 19 cases of neovascular age-related macular degeneration (AMD), 20 cases of diabetic macular edema (DME) and 25 cases of retinal vein occlusion (RVO). Twenty-nine cases were treated with aflibercept (2\u2009mg\/0.05\u2009mL) whereas 35 cases were managed with ranibizumab (0.5\u2009mg\/0.05\u2009mL). A corneal confocal microscope was used to collect images of corneal subbasal nerve plexus, and Image J was used for image analysis. The changes in corneal nerve were compared between 1 month after each injection and before injection. There were no significant differences in the density and length of corneal nerve at specific time after the surgery in comparison with baseline in patients who were given 3 intravitreal injections. There was no significant correlation between the numbers of injections and the changes of the corneal nerves. After 3rd injection, the nerve length of the DME group was markedly lower than that of AMD and RVO groups, the difference was statistically significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .05). The nerve density of the DME group was not significantly different from that of AMD and RVO groups, whereas the nerve length and nerve density of the AMD and RVO groups were not statistically significant between each other also. The corneal nerve length after the 2nd and 3rd injections of Aflibercept were lower than that before surgery, the difference was statistically significant. There were no significant differences in nerve density and nerve length at each time point after Ranibizumab injection. The length and density of the corneal nerve after multiple injections in contralateral eye displayed no significant changes compared with the baseline. Repeated intravitreal anti-VEGF drug can reduce the length of corneal nerves. For patients who need repeated intravitreal injections of anti-VEGF drugs, especially in DM, attention should be paid on the changes affecting the corneal nerves. It is also needed to strengthen the local anti-inflammatory therapy to avoid infection and to use artificial tears to protect the microenvironment of the ocular surface after the surgery.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000034210","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:47:20Z","timestamp":1689950840000},"page":"e34210","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2105-9920","authenticated-orcid":false,"given":"Yuanyuan","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"},{"name":"Dalian Medical University, Dalian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Third People\u2019s Hospital Affiliated to Dalian Medical University, Dalian, China"},{"name":"Key Laboratory of Corneal and Ocular Surface Diseases Research of Liaoning Province, Dalian, China"},{"name":"Dalian Medical University, Dalian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260710","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IAE.0b013e31813c68b7","article-title":"Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.","volume":"27","author":"Pawan","year":"2007","journal-title":"Retina"},{"issue":"Suppl 1","key":"R2-20260710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41433-020-0961-6","article-title":"Diabetic retinopathy and diabetic macular oedema pathways and management: UK consensus working group.","volume":"34","author":"Amoaku","year":"2020","journal-title":"Eye (Lond)"},{"key":"R3-20260710","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502041","article-title":"Guidelines for the management of retinal vein occlusion by the European society of retina specialists (EURETINA).","volume":"242","author":"Schmidt-Erfurth","year":"2019","journal-title":"Ophthalmologica"},{"key":"R4-20260710","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40942-017-0066-y","article-title":"Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration.","volume":"3","author":"Thiago","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"R5-20260710","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20260710","first-page":"2326","article-title":"Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.","volume":"13","author":"Dratviman-Storobinsky","year":"2009","journal-title":"Mol Vis"},{"key":"R7-20260710","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ICO.0000000000002836","article-title":"Corneal nerve fiber and sensitivity loss after repeated intravitreal anti-VEGF injections: an in vivo confocal microscopy study.","volume":"41","author":"Polat","year":"2022","journal-title":"Cornea"},{"key":"R8-20260710","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1167\/iovs.07-1129","article-title":"Safety profile of topical VEGF neutralization at the cornea.","volume":"50","author":"Bock","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20260710","doi-asserted-by":"crossref","first-page":"6004047","DOI":"10.1155\/2022\/6004047","article-title":"Efficacy and safety of antivascular endothelial growth factor (Anti-VEGF) in treating neovascular age-related macular degeneration (AMD): a systematic review and meta-analysis.","volume":"2022","author":"Yin","year":"2022","journal-title":"J Immunol Res"},{"key":"R10-20260710","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","article-title":"Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?","volume":"22","author":"Uludag","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"R11-20260710","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1177\/11206721221085870","article-title":"Long-term outcomes of anti-VEGF treatment of macular oedema due to retinal vein occlusions.","volume":"32","author":"Corazza","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"R12-20260710","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ophtha.2016.02.046","article-title":"Comprehensive review of ocular and systemic safety events with intravitreal aflibercept injection in randomized controlled trials.","volume":"123","author":"Kitchens","year":"2016","journal-title":"Ophthalmology"},{"key":"R13-20260710","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000088637","article-title":"Neuroprotective role of vascular endothelial growth factor: signaling mechanisms, biologic function, and therapeutic potential.","volume":"14","author":"Zachary","year":"2005","journal-title":"Neurosignals"},{"key":"R14-20260710","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20150124","article-title":"Vascular endothelial growth fac- tor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.","volume":"129","author":"Hulse","year":"2015","journal-title":"Clin Sci (Colch)"},{"key":"R15-20260710","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on M\u00fcller cells and photoreceptors.","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"R16-20260710","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1167\/iovs.15-18019","article-title":"Neuroanatomy and neurochemistry of mouse cornea.","volume":"57","author":"He","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260710","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exer.2009.12.010","article-title":"Anatomy of the human corneal innervation.","volume":"90","author":"Marfurt","year":"2010","journal-title":"Exp Eye Res"},{"key":"R18-20260710","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/aos.13844","article-title":"Role of corneal nerves in ocular surface homeostasis and disease.","volume":"97","author":"Labetoulle","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"R19-20260710","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1167\/iovs.16-20926","article-title":"Subconjunctival bevacizumab injection impairs corneal innervations and epithelial wound healing in mice.","volume":"58","author":"Dong","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20260710","doi-asserted-by":"crossref","first-page":"e0170271","DOI":"10.1371\/journal.pone.0170271","article-title":"Assessment of corneal sensation, innervation and retinal nerve fiber layer in patients treated with multiple intravitreal ranibizumab injections.","volume":"12","author":"Gulfidan","year":"2017","journal-title":"PLoS One"},{"key":"R21-20260710","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc14-2114","article-title":"Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes.","volume":"38","author":"Pritchard","year":"2015","journal-title":"Diabetes Care"},{"key":"R22-20260710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdiacomp.2017.09.002","article-title":"Ophthalmic and clinical factors that predict four-year development and worsening of diabetic retinopathy in type 1 diabetes.","volume":"32","author":"Srinivasan","year":"2018","journal-title":"J Diabetes Complications"},{"key":"R23-20260710","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00592-020-01511-x","article-title":"The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema.","volume":"57","author":"Di","year":"2020","journal-title":"Acta Diabetol"},{"key":"R24-20260710","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00417-017-3878-4","article-title":"Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.","volume":"256","author":"Huang","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20260710","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","article-title":"Corneal nerves in health and disease.","volume":"59","author":"Shaheen","year":"2014","journal-title":"Surv Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:01:00Z","timestamp":1783728060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":25,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034210","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}